Speckle-type POZ protein suppresses lipid accumulation and prostate cancer growth by stabilizing fatty acid synthase

被引:26
作者
Gang, Xiaokun [1 ]
Xuan, Lili [3 ]
Zhao, Xue [1 ]
Lv, You [1 ]
Li, Fei [1 ]
Wang, Yao [2 ]
Wang, Guixia [1 ]
机构
[1] Jilin Univ, Dept Endocrinol & Metab, Hosp 1, 71 Xinmin St, Changchun 130021, Jilin, Peoples R China
[2] Jilin Univ, Dept Orthopaed, Hosp 2, 218 Zigiang St, Changchun 130041, Jilin, Peoples R China
[3] Jilin Univ, Dept Obstet & Gynecol, China Japan Union Hosp, Changchun, Jilin, Peoples R China
基金
中国国家自然科学基金;
关键词
fatty acid synthase; lipid metabolism; mutation; prostate cancer; speckle-type POZ protein; SPOP; EXPRESSION; UBIQUITINATION; MUTATIONS; INSIGHTS;
D O I
10.1002/pros.23793
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Fatty acid synthase (FASN) is vital for maintaining lipid homeostasis in prostate cancer (PCa) cells, which have an increased rate of de novo fatty acid (FA) synthesis. Mutations in the gene encoding the tumor suppressor speckle-type POZ protein (SPOP), which is a E3 ubiquitin ligase, are a critical feature of PCa. Here, we provide evidence that FASN is a substrate of SPOP and that interaction of these proteins induces FASN ubiquitination and proteasome-dependent degradation. We showed that SPOP mutants commonly found in PCa cannot bind to FASN. Moreover, a decrease in SPOP levels upregulated FASN expression and triggered lipid accumulation in PCa cells. These results demonstrate that FASN is a crucial mediator of SPOP-induced inhibition of PCa cell growth. Our data provide evidence that SPOP regulates lipid metabolism by decreasing FASN expression and FA synthesis, resulting in tumor suppression. Taken together, our study indicates that this pathway may be a new therapeutic target for treating PCa.
引用
收藏
页码:864 / 871
页数:8
相关论文
共 20 条
[1]   Truncated ERG Oncoproteins from TMPRSS2-ERG Fusions Are Resistant to SPOP-Mediated Proteasome Degradation [J].
An, Jian ;
Ren, Shancheng ;
Murphy, Stephen J. ;
Dalangood, Sumiya ;
Chang, Cunjie ;
Pang, Xiaodong ;
Cui, Yangyan ;
Wang, Liguo ;
Pan, Yunqian ;
Zhang, Xiaowei ;
Zhu, Yasheng ;
Wang, Chenji ;
Halling, Geoffrey C. ;
Cheng, Liang ;
Sukov, William R. ;
Karnes, R. Jeffrey ;
Vasmatzis, George ;
Zhang, Qing ;
Zhang, Jun ;
Cheville, John C. ;
Yan, Jun ;
Sun, Yinghao ;
Huang, Haojie .
MOLECULAR CELL, 2015, 59 (06) :904-916
[2]   Destruction of Full-Length Androgen Receptor by Wild-Type SPOP, but Not Prostate-Cancer-Associated Mutants [J].
An, Jian ;
Wang, Chenji ;
Deng, Yibin ;
Yu, Long ;
Huang, Haojie .
CELL REPORTS, 2014, 6 (04) :657-669
[3]   Molecular features of the transition from prostatic intraepithelial neoplasia (PIN) to prostate cancer: Genome-wide gene-expression profiles of prostate cancers and PINs [J].
Ashida, S ;
Nakagawa, H ;
Katagiri, T ;
Furihata, M ;
Iiizumi, M ;
Anazawa, Y ;
Tsunoda, T ;
Takata, R ;
Kasahara, K ;
Miki, T ;
Fujioka, T ;
Shuin, T ;
Nakamura, Y .
CANCER RESEARCH, 2004, 64 (17) :5963-5972
[4]   Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer [J].
Barbieri, Christopher E. ;
Baca, Sylvan C. ;
Lawrence, Michael S. ;
Demichelis, Francesca ;
Blattner, Mirjam ;
Theurillat, Jean-Philippe ;
White, Thomas A. ;
Stojanov, Petar ;
Van Allen, Eliezer ;
Stransky, Nicolas ;
Nickerson, Elizabeth ;
Chae, Sung-Suk ;
Boysen, Gunther ;
Auclair, Daniel ;
Onofrio, Robert C. ;
Park, Kyung ;
Kitabayashi, Naoki ;
MacDonald, Theresa Y. ;
Sheikh, Karen ;
Vuong, Terry ;
Guiducci, Candace ;
Cibulskis, Kristian ;
Sivachenko, Andrey ;
Carter, Scott L. ;
Saksena, Gordon ;
Voet, Douglas ;
Hussain, Wasay M. ;
Ramos, Alex H. ;
Winckler, Wendy ;
Redman, Michelle C. ;
Ardlie, Kristin ;
Tewari, Ashutosh K. ;
Mosquera, Juan Miguel ;
Rupp, Niels ;
Wild, Peter J. ;
Moch, Holger ;
Morrissey, Colm ;
Nelson, Peter S. ;
Kantoff, Philip W. ;
Gabriel, Stacey B. ;
Golub, Todd R. ;
Meyerson, Matthew ;
Lander, Eric S. ;
Getz, Gad ;
Rubin, Mark A. ;
Garraway, Levi A. .
NATURE GENETICS, 2012, 44 (06) :685-U107
[5]   SPOP Mutations in Prostate Cancer across Demographically Diverse Patient Cohorts [J].
Blattner, Mirjam ;
Lee, Daniel J. ;
O'Reilly, Catherine ;
Park, Kyung ;
MacDonald, Theresa Y. ;
Khani, Francesca ;
Turner, Kevin R. ;
Chiu, Ya-Lin ;
Wild, Peter J. ;
Dolgalev, Igor ;
Heguy, Adriana ;
Sboner, Andrea ;
Ramazangolu, Sinan ;
Hieronymus, Haley ;
Sawyers, Charles ;
Tewari, Ashutosh K. ;
Moch, Holger ;
Yoon, Ghil Suk ;
Known, Yong Chul ;
Andren, Ove ;
Fall, Katja ;
Demichelis, Francecsa ;
Mosquera, Juan Miguel ;
Robinson, Brian D. ;
Barbieri, Christopher E. ;
Rubin, Mark A. .
NEOPLASIA, 2014, 16 (01) :14-U34
[6]   Fatty acid synthase - Modern tumor cell biology insights into a classical oncology target [J].
Buckley, Douglas ;
Duke, Gregory ;
Heuer, Timothy S. ;
O'Farrell, Marie ;
Wagman, Allan S. ;
McCulloch, William ;
Kemble, George .
PHARMACOLOGY & THERAPEUTICS, 2017, 177 :23-31
[7]   Lipid pathway deregulation in advanced prostate cancer [J].
Galbraith, Laura ;
Leung, Hing Y. ;
Ahmad, Imran .
PHARMACOLOGICAL RESEARCH, 2018, 131 :177-184
[8]   SPOP Promotes Ubiquitination and Degradation of the ERG Oncoprotein to Suppress Prostate Cancer Progression [J].
Gan, Wenjian ;
Dai, Xiangpeng ;
Lunardi, Andrea ;
Li, Zhen ;
Inuzuka, Hiroyuki ;
Liu, Pengda ;
Varmeh, Shoreh ;
Zhang, Jinfang ;
Cheng, Liang ;
Sun, Yin ;
Asara, John M. ;
Beck, Andrew H. ;
Huang, Jiaoti ;
Pandolfi, Pier Paolo ;
Wei, Wenyi .
MOLECULAR CELL, 2015, 59 (06) :917-930
[9]   P300 acetyltransferase regulates fatty acid synthase expression, lipid metabolism and prostate cancer growth [J].
Gang, Xiaokun ;
Yang, Yinhui ;
Zhong, Jian ;
Jiang, Kui ;
Pan, Yunqian ;
Karnes, R. Jeffrey ;
Zhang, Jun ;
Xu, Wanhai ;
Wang, Guixia ;
Huang, Haojie .
ONCOTARGET, 2016, 7 (12) :15135-15149
[10]   BTB domain-containing speckle-type POZ protein (SPOP) serves as an adaptor of Daxx for ubiquitination by Cul3-based ubiquitin ligase [J].
Kwon, JE ;
La, M ;
Oh, KH ;
Oh, YM ;
Kim, GR ;
Seol, JH ;
Baek, SH ;
Chiba, T ;
Tanaka, K ;
Bang, OS ;
Joe, CO ;
Chung, CH .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (18) :12664-12672